Developing Transformative Cell and Exosome-based Therapeutics

Capricor Therapeutics is a biotechnology company offering a new approach on drug development in Duchenne muscular dystrophy and beyond. We are patient-focused first, while advancing precision medicine.

Learn More About Us View Our Corporate Deck

Optimizing Patient-focused Medicine

We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases.

View Our Pipeline

Accelerating the Development of Precision Science

Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.

Explore Our Science

Latest News

View All